Showcase

公司名稱 Company Name

六捷生物科技（香港）有限公司
6J Biotechnology (Hong Kong) Limited

公司網站 Company Website 

https://6jbiotech.com

公司簡介 Company Background
6J Biotechnology（香港）有限公司專注於內體運輸靶向創新藥研發，核心產品6J-2為全球首創抗腫瘤轉移小分子，目前已推進至臨床一期准備階段。公司已入選港深創科園GAS計劃，計劃在園區開展臨床研究推進及轉化應用，加速創新藥物的產業化落地。
6J Biotechnology (Hong Kong) Limited focuses on the development of innovative therapeutics targeting endosomal transport. Its lead candidate, 6J-2, is a first-in-class small molecule designed to inhibit tumor metastasis and is currently advancing toward Phase I clinical trials. The company has been selected for the GASE (GAS) Program at the Hong Kong-Shenzhen Innovation and Technology Park. At the Park, the company aims to advance early-stage clinical development and accelerate the translation and commercialization of its innovative drug candidate.
陳列產品之簡介 Description of displayed product
6J-2為公司自主研發的創新抗腫瘤轉移小分子藥物，靶向內體運輸關鍵通路，目前已完成片劑劑型開發並具備良好成藥性。該產品正處於臨床前向臨床一期過渡階段，具有明確的機制創新性與廣闊的臨床應用前景。
6J-2 is a proprietary, first-in-class small molecule developed by the company to inhibit tumor metastasis by targeting key endosomal transport pathways. It has been successfully formulated into a tablet dosage form with favorable drug-like properties. The product is currently transitioning from preclinical studies to Phase I clinical trials and demonstrates strong mechanistic innovation with promising clinical potential.
公司產品 Company products